Brain mechanisms contributing to sympathetic hyperactivity and heart failure.
Leenen
Frans H H
FH
D000808:Angiotensinogen / Q000037:antagonists & inhibitors / Q000235:genetics; D000818:Animals; D030801:Animals, Genetically Modified; D018014:Gene Transfer Techniques; D006333:Heart Failure / Q000209:etiology / Q000503:physiopathology*; D007263:Infusions, Parenteral; D016753:Interleukin-10 / Q000235:genetics / Q000502:physiology*; D008955:Models, Cardiovascular; D008959:Models, Neurological; D009203:Myocardial Infarction / Q000150:complications; D009638:Norepinephrine / Q000097:blood; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism / Q000503:physiopathology*; D016372:RNA, Antisense / Q000235:genetics / Q000494:pharmacology; D012333:RNA, Messenger / Q000037:antagonists & inhibitors; D051381:Rats; D017207:Rats, Sprague-Dawley; D013148:Spironolactone / Q000008:administration & dosage / Q000494:pharmacology; D013495:Supraoptic Nucleus / Q000503:physiopathology; D013564:Sympathetic Nervous System / Q000503:physiopathology*; D020257:Ventricular Remodeling
D016372:RNA, Antisense; D012333:RNA, Messenger; D000808:Angiotensinogen; D016753:Interleukin-10; D013148:Spironolactone; D009638:Norepinephrine